Free Trial

CRH (CRH) Financials

CRH logo
$91.57 -0.39 (-0.43%)
As of 11:07 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for CRH

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
3,492 3,178 3,862 2,630 1,304 - 2,889 2,240 1,280 685
Consolidated Net Income / (Loss)
3,521 3,072 3,889 2,686 1,165 1,738 2,889 2,305 1,336 792
Net Income / (Loss) Continuing Operations
3,521 3,072 2,699 2,507 1,009 - 1,526 2,010 1,251 700
Total Pre-Tax Income
4,714 4,014 3,461 3,102 1,454 - 1,993 2,024 1,704 1,000
Total Operating Income
4,925 4,186 3,809 3,327 2,026 - 2,446 2,315 2,007 1,267
Total Gross Profit
12,701 11,963 10,815 9,827 8,565 9,273 9,058 8,863 8,651 7,240
Total Revenue
35,572 34,949 32,723 29,206 25,888 - 27,424 26,011 26,078 23,259
Operating Revenue
35,572 34,949 32,723 29,206 25,888 - 27,424 26,011 26,078 23,259
Total Cost of Revenue
22,871 22,986 21,908 19,379 17,323 - 18,391 17,148 17,427 16,019
Operating Cost of Revenue
22,871 22,986 21,908 19,379 17,323 - 18,391 17,148 17,427 16,019
Total Operating Expenses
7,776 7,777 7,006 6,500 6,539 - 6,612 6,548 6,643 5,973
Selling, General & Admin Expense
7,852 7,486 7,056 6,538 - - - - - -
Impairment Charge
161 357 0.00 0.00 - - - - - -
Other Special Charges / (Income)
-237 -66 -50 -38 - - - - - -
Total Other Income / (Expense), net
-211 -172 -348 -225 -589 - -453 -356 -359 -375
Interest Expense
612 376 344 315 438 - - 362 411 431
Interest & Investment Income
143 206 65 0.00 0.00 - - 14 8.42 8.69
Other Income / (Expense), net
258 -2.00 -69 90 -151 - -453 -8.41 44 48
Income Tax Expense
1,085 925 762 650 445 - 467 14 453 300
Other Gains / (Losses), net
-108 -17 0.00 55 - - - - - -
Net Income / (Loss) Discontinued Operations
0.00 0.00 1,190 179 312 - 1,388 296 85 92
Net Income / (Loss) Attributable to Noncontrolling Interest
29 -106 27 56 - - - - - -
Basic Earnings per Share
$5.06 $4.36 $5.15 $3.35 $1.43 - - $2.72 $1.50 $0.89
Weighted Average Basic Shares Outstanding
683.30M 723.90M 758.30M 780.20M 795.14M 799.64M 843.39M 838.96M - -
Diluted Earnings per Share
$5.02 $4.33 $5.11 $3.32 $1.42 - - $2.71 $1.49 $0.89
Weighted Average Diluted Shares Outstanding
689.50M 729.20M 764.10M 786.80M 795.14M 799.64M 843.39M 838.96M - -
Weighted Average Basic & Diluted Shares Outstanding
676.48M 690.36M 752.14M 774.14M 795.14M 799.64M 843.39M 838.96M - -
Cash Dividends to Common per Share
$1.40 $1.33 $1.27 $1.21 - - - - - -

Quarterly Income Statements for CRH

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Income / (Loss) Attributable to Common Shareholders
-94 703 1,376 1,297 116 701 1,306 1,199 -28
Consolidated Net Income / (Loss)
-98 709 1,389 1,309 114 573 1,318 1,212 -31
Net Income / (Loss) Continuing Operations
-98 709 1,389 1,309 114 573 1,318 1,212 -31
Total Pre-Tax Income
-146 987 1,895 1,733 99 755 1,720 1,578 -39
Total Operating Income
18 1,104 1,964 1,829 28 783 1,788 1,613 2.00
Total Gross Profit
1,837 3,160 4,059 3,675 1,807 2,951 3,763 3,630 1,619
Total Revenue
6,756 8,870 10,515 9,654 6,533 8,685 10,128 9,709 6,427
Operating Revenue
6,756 8,870 10,515 9,654 6,533 8,685 10,128 9,709 6,427
Total Cost of Revenue
4,919 5,710 6,456 5,979 4,726 5,734 6,365 6,079 4,808
Operating Cost of Revenue
4,919 5,710 6,456 5,979 4,726 5,734 6,365 6,079 4,808
Total Operating Expenses
1,819 2,056 2,095 1,846 1,779 2,168 1,975 2,017 1,617
Selling, General & Admin Expense
1,833 1,933 2,184 1,948 1,787 1,839 1,990 2,035 1,622
Other Special Charges / (Income)
-14 -38 -89 -102 -8.00 -28 -15 -18 -5.00
Total Other Income / (Expense), net
-164 -117 -69 -96 71 -28 -68 -35 -41
Interest Expense
181 160 164 155 133 91 131 73 81
Interest & Investment Income
37 31 33 36 43 68 62 36 40
Other Income / (Expense), net
-20 12 62 23 161 -5.00 1.00 2.00 0.00
Income Tax Expense
-58 143 531 430 -19 144 416 379 -14
Other Gains / (Losses), net
-10 -135 25 6.00 -4.00 -38 14 13 -6.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-4.00 6.00 13 12 -2.00 -128 12 13 -3.00
Basic Earnings per Share
($0.15) $1.02 $1.99 $1.89 $0.16 $0.97 $1.81 $1.63 ($0.05)
Weighted Average Basic Shares Outstanding
676.70M 683.30M 681.60M 685.50M 687.80M 723.90M 718.20M 734.70M 742.90M
Diluted Earnings per Share
($0.15) $1.01 $1.97 $1.88 $0.16 $0.96 $1.80 $1.62 ($0.05)
Weighted Average Diluted Shares Outstanding
676.70M 689.50M 685.50M 688.80M 693.40M 729.20M 722.10M 738.20M 742.90M
Weighted Average Basic & Diluted Shares Outstanding
676.00M 676.48M 679.34M 682.78M 686.68M 690.36M - - -
Cash Dividends to Common per Share
$0.37 - $0.35 $0.35 $0.35 - $0.25 $0.00 $1.03

Annual Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-2,631 454 153 -1,938 3,466 1,552 -5,946 -5,388 -4,133 -4,181
Net Cash From Operating Activities
4,989 5,017 3,800 3,979 4,116 3,881 -3,885 -2,392 -1,510 1,057
Net Cash From Continuing Operating Activities
4,989 5,017 3,800 3,979 4,116 2,580 -3,885 -2,392 -1,510 1,057
Net Income / (Loss) Continuing Operations
3,521 3,072 3,889 2,686 1,165 2,181 0.00 0.00 0.00 0.00
Consolidated Net Income / (Loss)
3,521 3,072 3,889 2,686 1,165 2,181 - - - -
Depreciation Expense
1,798 1,633 1,577 1,551 1,624 1,721 1,265 1,208 1,061 916
Non-Cash Adjustments To Reconcile Net Income
-14 547 -1,242 27 1,185 -1,024 -4,539 -3,285 -2,511 205
Changes in Operating Assets and Liabilities, net
-316 -235 -424 -285 142 -364 -611 -315 -60 -64
Net Cash From Investing Activities
-6,291 -2,391 -917 -2,513 -1,347 217 -5,400 -3,466 -1,054 -8,886
Net Cash From Continuing Investing Activities
-6,291 -2,397 -917 -2,513 -1,347 -2,040 -5,400 -3,466 -1,054 -8,886
Purchase of Property, Plant & Equipment
-2,578 -1,817 -1,523 -1,554 -996 -1,374 -1,324 -1,254 - -
Acquisitions
-4,900 -640 -3,253 -1,494 -351 -727 -4,076 -2,211 - -
Purchase of Investments
-9.00 -1.00 -11 0.00 - - - - - -
Sale of Property, Plant & Equipment
272 104 115 387 - - - - -897 -958
Divestitures
1,001 0.00 3,712 120 - - - - -157 -7,927
Sale and/or Maturity of Investments
44 44 36 32 - 39 - - - -
Other Investing Activities, net
-121 -87 7.00 -4.00 - 22 - - - -
Net Cash From Financing Activities
-1,186 -2,380 -2,499 -3,107 697 2,546 3,339 470 -1,570 3,648
Net Cash From Continuing Financing Activities
-1,186 -2,378 -2,499 -3,107 697 -2,485 3,339 470 -1,570 3,648
Repayment of Debt
-1,859 -1,462 -364 -1,183 -4,943 -996 -291 -434 0.00 -41
Repurchase of Common Equity
-1,482 -3,067 -1,178 -896 -249 -954 -921 -3.60 - -
Payment of Dividends
-1,740 -975 -943 -946 -722 -663 -633 -573 -379 -416
Issuance of Debt
4,001 3,163 38 0.00 6,611 106 5,184 1,480 -1,191 4,105
Other Financing Activities, net
-106 -37 -52 -82 - 22 - - - -
Effect of Exchange Rate Changes
-143 208 -231 -297 - - - - - -
Cash Interest Paid
599 418 329 340 432 - 394 381 364 328
Cash Income Taxes Paid
960 959 1,043 642 - - - - - -

Quarterly Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Change in Cash & Equivalents
-407 679 -866 637 -3,081 668 1,447 -375 -1,286
Net Cash From Operating Activities
-659 2,730 1,486 1,485 -712 2,423 1,631 1,634 -671
Net Cash From Continuing Operating Activities
-659 2,730 1,486 1,485 -712 2,423 1,631 1,634 -671
Net Income / (Loss) Continuing Operations
-98 709 1,389 1,309 114 573 1,318 1,212 -31
Consolidated Net Income / (Loss)
-98 709 1,389 1,309 114 573 1,318 1,212 -31
Depreciation Expense
477 510 467 424 397 446 402 401 384
Non-Cash Adjustments To Reconcile Net Income
16 326 -155 -80 -105 451 16 44 36
Changes in Operating Assets and Liabilities, net
-1,054 1,185 -215 -168 -1,118 953 -105 -23 -1,060
Net Cash From Investing Activities
-964 -1,886 -1,788 -521 -2,096 -662 -759 -478 -492
Net Cash From Continuing Investing Activities
-964 -1,886 -1,788 -521 -2,096 -668 -759 -478 -492
Purchase of Property, Plant & Equipment
-645 -943 -505 -624 -506 -642 -404 -439 -332
Acquisitions
-585 -1,047 -1,331 -316 -2,206 -79 -363 -43 -155
Purchase of Investments
20 12 -18 10 -13 -4.00 -4.00 9.00 -2.00
Sale of Property, Plant & Equipment
35 -908 84 357 739 40 22 36 6.00
Divestitures
36 919 27 - - -5.00 5.00 - -
Sale and/or Maturity of Investments
9.00 22 7.00 9.00 6.00 21 11 4.00 8.00
Other Investing Activities, net
166 59 -52 -12 -116 1.00 -26 -45 -17
Net Cash From Financing Activities
1,141 -42 -629 -339 -176 -1,283 649 -1,555 -191
Net Cash From Continuing Financing Activities
1,141 -42 -629 -339 -176 -1,281 649 -1,555 -191
Repayment of Debt
-1,533 -5.00 -163 -1,040 -651 -522 -91 -849 0.00
Repurchase of Common Equity
-310 -258 -317 -348 -559 -1,036 -1,072 -713 -246
Payment of Dividends
-17 -238 -249 -486 -767 -179 -12 -771 -13
Issuance of Debt
3,017 549 82 1,552 1,818 476 1,832 784 71
Other Financing Activities, net
-16 -90 18 -17 -17 -20 -8.00 -6.00 -3.00
Effect of Exchange Rate Changes
75 -123 65 12 -97 190 -74 24 68
Cash Interest Paid
63 227 156 171 45 174 43 147 54
Cash Income Taxes Paid
134 306 350 145 159 339 343 173 104

Annual Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Total Assets
50,613 47,469 45,319 44,670 44,944 47,612 46,777 37,999 33,237
Total Current Assets
14,083 16,885 14,833 14,044 14,977 17,258 17,395 11,737 9,882
Cash & Equivalents
3,720 6,341 5,936 5,783 7,721 9,918 9,191 2,541 2,576
Restricted Cash
39 0.00 - - - - - - -
Accounts Receivable
4,820 4,507 4,300 4,569 4,086 4,231 4,665 4,361 4,186
Inventories, net
4,755 4,291 4,194 3,611 3,117 3,080 3,505 3,261 3,092
Other Current Assets
749 478 403 - - - - - -
Other Current Nonoperating Assets
0.00 1,268 - - - - - - -
Plant, Property, & Equipment, net
21,452 17,841 17,768 19,502 19,317 19,574 18,046 15,729 13,350
Total Noncurrent Assets
15,078 12,743 12,718 11,124 10,650 10,780 11,336 10,533 10,005
Long-Term Investments
737 620 649 653 626 775 1,332 1,499 1,367
Goodwill
11,061 9,158 9,199 - - - - - -
Intangible Assets
1,211 1,041 1,088 9,848 9,373 9,475 9,656 8,666 8,165
Other Noncurrent Operating Assets
2,069 1,924 1,782 275 197 98 60 66 83
Total Liabilities & Shareholders' Equity
50,613 47,469 45,319 44,670 44,944 47,612 46,777 37,999 33,237
Total Liabilities
27,763 25,848 22,279 23,756 24,596 27,977 27,825 20,008 18,043
Total Current Liabilities
10,296 10,013 8,041 7,581 7,465 13,411 14,006 7,516 6,690
Short-Term Debt
2,999 1,866 1,491 549 1,257 6,616 7,213 380 289
Accounts Payable
3,207 3,149 2,930 6,409 5,503 5,461 5,817 5,718 5,550
Accrued Expenses
2,248 2,296 2,132 - - - - - -
Other Current Liabilities
1,842 2,327 1,488 790 797 769 468 869 436
Other Current Nonoperating Liabilities
0.00 375 0.00 - - - - - -
Total Noncurrent Liabilities
17,467 15,835 14,238 16,175 17,131 14,566 13,819 12,492 11,353
Long-Term Debt
10,969 9,776 8,145 9,938 10,958 9,211 9,959 9,202 7,906
Noncurrent Deferred & Payable Income Tax Liabilities
3,105 2,738 2,885 2,734 2,613 2,627 2,530 2,001 2,112
Other Noncurrent Operating Liabilities
3,393 3,321 3,208 937 954 855 844 836 713
Commitments & Contingencies
0.00 0.00 0.00 - - - - - -
Redeemable Noncontrolling Interest
384 333 308 - - - - - -
Total Equity & Noncontrolling Interests
22,466 21,288 22,732 20,914 20,347 19,634 18,951 17,990 15,193
Total Preferred & Common Equity
21,607 20,854 22,157 20,233 40,004 19,027 18,349 17,406 14,616
Preferred Stock
1.00 1.00 1.00 - 7,493 - - - -
Total Common Equity
21,606 20,853 22,156 20,232 12,162 19,027 18,349 17,406 14,616
Common Stock
712 750 745 309 333 335 352 344 299
Retained Earnings
24,036 22,918 22,495 19,770 11,565 11,350 11,705 9,493 6,809
Treasury Stock
-2,137 -2,199 -297 -195 -386 -360 -920 -18 -15
Accumulated Other Comprehensive Income / (Loss)
-1,005 -616 -787 - - - - - -
Noncontrolling Interest
859 434 575 681 692 607 602 584 576

Quarterly Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023
Total Assets
51,921 51,221 48,105 46,333 47,631 46,142 45,107
Total Current Assets
14,242 14,840 15,113 13,709 16,315 15,074 14,230
Cash & Equivalents
3,352 2,978 3,066 3,308 5,722 4,275 4,650
Restricted Cash
0.00 102 869 - 0.00 0.00 -
Accounts Receivable
5,141 6,422 5,893 4,798 5,972 6,119 4,706
Inventories, net
4,960 4,644 4,514 4,619 4,191 4,276 4,458
Other Current Assets
789 694 704 748 430 404 416
Other Current Nonoperating Assets
0.00 0.00 67 236 0.00 0.00 0.00
Plant, Property, & Equipment, net
22,179 21,289 19,235 18,878 18,103 18,155 17,997
Total Noncurrent Assets
15,500 15,092 13,757 13,746 13,213 12,913 12,880
Long-Term Investments
732 929 484 609 665 672 655
Goodwill
11,475 10,906 10,251 10,125 9,545 9,338 9,308
Intangible Assets
1,208 1,105 1,086 1,093 1,074 1,061 1,094
Other Noncurrent Operating Assets
2,085 2,152 1,936 1,919 1,929 1,842 1,823
Total Liabilities & Shareholders' Equity
51,921 51,221 48,105 46,333 47,631 46,142 45,107
Total Liabilities
29,564 28,055 26,654 25,591 24,983 23,433 22,963
Total Current Liabilities
8,712 10,668 10,548 9,997 9,191 9,671 9,255
Short-Term Debt
1,458 3,218 3,218 2,992 1,860 2,185 2,251
Accounts Payable
2,777 2,963 3,363 2,730 2,954 3,553 2,627
Accrued Expenses
2,270 2,513 2,272 2,241 2,457 2,335 2,079
Other Current Liabilities
2,207 1,974 1,681 1,990 1,920 1,598 2,298
Other Current Nonoperating Liabilities
0.00 0.00 14 44 0.00 0.00 0.00
Total Noncurrent Liabilities
20,852 17,387 16,106 15,594 15,792 13,762 13,708
Long-Term Debt
14,213 10,672 9,900 9,680 9,535 7,563 7,583
Noncurrent Deferred & Payable Income Tax Liabilities
3,141 3,168 2,914 2,684 3,050 3,010 2,972
Other Noncurrent Operating Liabilities
3,498 3,547 3,292 3,230 3,207 3,189 3,153
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
379 361 335 326 320 313 307
Total Equity & Noncontrolling Interests
21,978 22,805 21,116 20,416 22,328 22,396 21,837
Total Preferred & Common Equity
21,119 21,875 20,726 20,015 21,767 21,821 21,255
Preferred Stock
1.00 1.00 1.00 1.00 1.00 1.00 1.00
Total Common Equity
21,118 21,874 20,725 20,014 21,766 21,820 21,254
Common Stock
587 683 651 631 725 693 722
Retained Earnings
23,375 23,831 23,030 22,346 23,936 22,892 21,692
Treasury Stock
-2,038 -2,141 -2,143 -2,166 -2,132 -1,140 -487
Accumulated Other Comprehensive Income / (Loss)
-806 -499 -813 -797 -763 -625 -673
Noncontrolling Interest
859 930 390 401 561 575 582

Annual Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
1.78% 6.80% 12.04% 12.82% 0.00% 0.00% 5.43% -0.26% 12.12% 0.00%
EBITDA Growth
20.01% 9.40% 7.03% 41.98% 95.80% -45.15% -9.14% 12.91% 39.55% 0.00%
EBIT Growth
23.88% 11.87% 9.45% 82.24% 0.00% -100.00% -16.16% 12.43% 56.03% 0.00%
NOPAT Growth
17.70% 8.45% 12.95% 87.05% 0.00% -100.00% -18.51% 56.01% 66.12% 0.00%
Net Income Growth
14.62% -21.01% 44.79% 130.56% -32.97% -39.84% 25.33% 72.54% 68.67% 0.00%
EPS Growth
15.94% -15.26% 53.92% 133.80% 0.00% 0.00% 0.00% 81.60% 68.09% 0.00%
Operating Cash Flow Growth
-0.56% 32.03% -4.50% -3.33% 6.06% 199.90% -62.44% -58.43% -242.79% 0.00%
Free Cash Flow Firm Growth
-179.97% 22.77% 70.22% -7.67% 454.28% 63.29% -257.21% 97.57% 0.00% 0.00%
Invested Capital Growth
27.21% -2.61% -0.79% 2.98% -2.36% 2.23% 15.47% 14.08% 0.00% 0.00%
Revenue Q/Q Growth
0.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
6.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
6.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
8.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
4.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
1.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
6.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-2.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
35.71% 34.23% 33.05% 33.65% 33.08% 0.00% 33.03% 34.07% 33.17% 31.13%
EBITDA Margin
19.63% 16.64% 16.25% 17.01% 13.52% 0.00% 11.88% 13.51% 11.94% 9.59%
Operating Margin
13.85% 11.98% 11.64% 11.39% 7.83% 0.00% 8.92% 8.90% 7.70% 5.45%
EBIT Margin
14.57% 11.97% 11.43% 11.70% 7.24% 0.00% 7.27% 8.87% 7.87% 5.65%
Profit (Net Income) Margin
9.90% 8.79% 11.88% 9.20% 4.50% 0.00% 10.53% 8.86% 5.12% 3.41%
Tax Burden Percent
74.69% 76.53% 112.37% 86.59% 80.12% 0.00% 144.96% 113.89% 78.40% 79.24%
Interest Burden Percent
90.95% 95.94% 92.54% 90.78% 77.55% 0.00% 100.00% 87.76% 83.08% 76.03%
Effective Tax Rate
23.02% 23.04% 22.02% 20.95% 30.61% 0.00% 23.43% 0.71% 26.60% 30.00%
Return on Invested Capital (ROIC)
13.13% 12.51% 11.34% 10.15% 5.44% 0.00% 7.85% 11.06% 15.17% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
9.06% 8.14% 33.12% 11.21% 1.33% 0.00% 26.67% 11.22% 8.68% 0.00%
Return on Net Nonoperating Assets (RNNOA)
2.70% 1.25% 6.36% 2.87% 0.39% 0.00% 7.80% 2.84% 2.42% 0.00%
Return on Equity (ROE)
15.84% 13.76% 17.70% 13.02% 5.83% 9.01% 15.64% 13.89% 17.59% 0.00%
Cash Return on Invested Capital (CROIC)
-10.81% 15.16% 12.14% 7.21% 7.83% -2.21% -6.52% -2.09% -184.83% 0.00%
Operating Return on Assets (OROA)
10.57% 9.02% 8.31% 7.63% 4.05% 0.00% 4.70% 6.48% 6.17% 0.00%
Return on Assets (ROA)
7.18% 6.62% 8.64% 5.99% 2.52% 0.00% 6.82% 6.47% 4.02% 0.00%
Return on Common Equity (ROCE)
15.12% 13.25% 17.07% 10.22% 4.55% 8.73% 15.14% 13.41% 16.92% 0.00%
Return on Equity Simple (ROE_SIMPLE)
16.30% 14.73% 17.55% 13.28% 2.91% 9.13% 15.74% 13.24% 9.14% 0.00%
Net Operating Profit after Tax (NOPAT)
3,791 3,221 2,970 2,630 1,406 0.00 1,873 2,298 1,473 887
NOPAT Margin
10.66% 9.22% 9.08% 9.00% 5.43% 0.00% 6.83% 8.84% 5.65% 3.81%
Net Nonoperating Expense Percent (NNEP)
4.08% 4.37% -21.78% -1.06% 4.11% -26.43% -18.82% -0.16% 6.49% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
10.41% 9.78% 9.18% - - - - - - -
Cost of Revenue to Revenue
64.30% 65.77% 66.95% 66.35% 66.92% 0.00% 67.06% 65.93% 66.83% 68.87%
SG&A Expenses to Revenue
22.07% 21.42% 21.56% 22.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.86% 22.25% 21.41% 22.26% 25.26% 0.00% 24.11% 25.17% 25.48% 25.68%
Earnings before Interest and Taxes (EBIT)
5,183 4,184 3,740 3,417 1,875 0.00 1,993 2,306 2,051 1,315
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6,981 5,817 5,317 4,968 3,499 1,787 3,258 3,515 3,113 2,231
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.91 2.46 1.30 2.03 2.68 1.65 1.09 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
6.73 4.81 2.43 3.96 11.67 3.29 2.29 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.77 1.46 0.88 1.41 1.26 0.00 0.73 0.00 0.00 0.00
Price to Earnings (P/E)
18.00 16.11 7.46 15.65 24.95 0.00 6.90 0.00 0.00 0.00
Dividend Yield
0.00% 1.95% 0.00% 2.26% 2.23% 2.15% 3.41% 2.27% 2.38% 2.84%
Earnings Yield
5.56% 6.21% 13.41% 6.39% 4.01% 0.00% 14.48% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.28 2.23 1.25 1.80 1.80 1.48 1.06 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
2.07 1.62 1.00 1.62 1.77 0.00 0.99 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
10.54 9.74 6.16 9.51 13.12 21.60 8.34 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
14.19 13.54 8.75 13.82 24.49 0.00 13.64 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
19.40 17.58 11.02 17.96 32.65 0.00 14.51 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.75 11.29 8.62 11.87 11.15 9.95 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 14.51 10.30 25.28 22.69 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.61 0.54 0.42 0.57 0.67 0.88 0.91 0.53 0.54 0.00
Long-Term Debt to Equity
0.48 0.45 0.35 0.54 0.60 0.54 0.53 0.51 0.52 0.00
Financial Leverage
0.30 0.15 0.19 0.26 0.29 0.34 0.29 0.25 0.28 0.00
Leverage Ratio
2.21 2.08 2.05 2.17 2.32 2.45 2.29 2.15 2.19 0.00
Compound Leverage Factor
2.01 1.99 1.89 1.97 1.80 0.00 2.29 1.88 1.82 0.00
Debt to Total Capital
37.94% 35.00% 29.49% 36.19% 39.98% 46.72% 47.54% 34.75% 35.04% 0.00%
Short-Term Debt to Total Capital
8.15% 5.61% 4.56% 1.68% 3.71% 17.95% 19.97% 1.38% 1.24% 0.00%
Long-Term Debt to Total Capital
29.79% 29.39% 24.93% 34.51% 36.27% 28.77% 27.57% 33.37% 33.80% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 22.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.38% 2.31% 2.70% 2.08% 2.04% 1.65% 1.67% 2.12% 2.46% 0.00%
Common Equity to Total Capital
58.68% 62.69% 67.81% 61.73% 35.88% 51.63% 50.80% 63.13% 62.50% 0.00%
Debt to EBITDA
2.00 2.00 1.81 2.39 3.87 9.64 5.27 2.73 2.63 0.00
Net Debt to EBITDA
1.36 0.80 0.57 1.08 1.48 3.65 2.04 1.56 1.36 0.00
Long-Term Debt to EBITDA
1.57 1.68 1.53 2.28 3.51 5.93 3.06 2.62 2.54 0.00
Debt to NOPAT
3.68 3.61 3.24 4.51 9.64 0.00 9.17 4.17 5.56 0.00
Net Debt to NOPAT
2.50 1.45 1.03 2.05 3.69 0.00 3.54 2.39 2.87 0.00
Long-Term Debt to NOPAT
2.89 3.03 2.74 4.30 8.75 0.00 5.32 4.00 5.37 0.00
Altman Z-Score
3.15 3.07 2.64 2.74 2.07 1.11 1.59 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
4.52% 3.70% 3.56% 21.49% 21.99% 3.13% 3.21% 3.50% 3.79% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.37 1.69 1.84 1.85 2.01 1.29 1.24 1.56 1.48 0.00
Quick Ratio
0.83 1.08 1.27 1.37 1.58 1.06 0.99 0.92 1.01 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,122 3,903 3,179 1,868 2,023 -571 -1,555 -435 -17,949 0.00
Operating Cash Flow to CapEx
216.35% 292.88% 269.89% 340.96% 413.25% 282.46% -293.43% -190.71% -168.23% 110.32%
Free Cash Flow to Firm to Interest Expense
-5.10 10.38 9.24 5.93 4.62 0.00 0.00 -1.20 -43.64 0.00
Operating Cash Flow to Interest Expense
8.15 13.34 11.05 12.63 9.40 0.00 0.00 -6.61 -3.67 2.45
Operating Cash Flow Less CapEx to Interest Expense
4.38 8.79 6.95 8.93 7.12 0.00 0.00 -10.08 -5.85 0.23
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.73 0.75 0.73 0.65 0.56 0.00 0.65 0.73 0.78 0.00
Accounts Receivable Turnover
7.63 7.94 7.38 6.75 6.23 0.00 6.08 6.09 6.23 0.00
Inventory Turnover
5.06 5.42 5.61 5.76 5.59 0.00 5.44 5.40 5.64 0.00
Fixed Asset Turnover
1.81 1.96 1.76 1.50 1.33 0.00 1.62 1.79 1.95 0.00
Accounts Payable Turnover
7.20 7.56 4.69 3.25 3.16 0.00 3.19 3.04 3.14 0.00
Days Sales Outstanding (DSO)
47.85 45.99 49.46 54.08 58.63 0.00 60.06 59.97 58.59 0.00
Days Inventory Outstanding (DIO)
72.18 67.37 65.02 63.36 65.29 0.00 67.15 67.62 64.76 0.00
Days Payable Outstanding (DPO)
50.72 48.26 77.80 112.18 115.51 0.00 114.46 119.93 116.25 0.00
Cash Conversion Cycle (CCC)
69.32 65.09 36.68 5.26 8.41 0.00 12.74 7.66 7.10 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
32,322 25,409 26,091 26,300 25,538 26,155 25,584 22,156 19,422 0.00
Invested Capital Turnover
1.23 1.36 1.25 1.13 1.00 0.00 1.15 1.25 2.69 0.00
Increase / (Decrease) in Invested Capital
6,913 -682 -209 762 -617 571 3,428 2,734 19,422 0.00
Enterprise Value (EV)
73,568 56,643 32,740 47,228 45,909 38,598 27,179 0.00 0.00 0.00
Market Capitalization
62,852 51,194 28,805 41,161 32,534 31,471 19,945 0.00 0.00 0.00
Book Value per Share
$31.80 $27.72 $29.22 $25.44 $15.21 $22.56 $21.87 $20.75 $0.00 $0.00
Tangible Book Value per Share
$13.74 $14.16 $15.65 $13.06 $3.49 $11.33 $10.36 $10.42 $0.00 $0.00
Total Capital
36,818 33,263 32,676 32,775 33,901 36,854 36,123 27,571 23,388 0.00
Total Debt
13,968 11,642 9,636 11,861 13,554 17,220 17,172 9,581 8,195 0.00
Total Long-Term Debt
10,969 9,776 8,145 11,312 12,297 10,604 9,959 9,202 7,906 0.00
Net Debt
9,472 4,681 3,051 5,386 5,190 6,520 6,632 5,501 4,228 0.00
Capital Expenditures (CapEx)
2,306 1,713 1,408 1,167 996 1,374 1,324 1,254 897 958
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,027 2,397 2,347 1,190 1,031 538 1,394 2,019 882 0.00
Debt-free Net Working Capital (DFNWC)
6,786 8,738 8,283 7,012 8,769 10,463 10,602 4,601 3,482 0.00
Net Working Capital (NWC)
3,787 6,872 6,792 6,463 7,512 3,847 3,389 4,221 3,193 0.00
Net Nonoperating Expense (NNE)
270 149 -919 -56 241 -1,738 -1,016 -6.88 137 95
Net Nonoperating Obligations (NNO)
9,472 3,788 3,051 5,386 5,191 6,521 6,633 4,166 4,229 0.00
Total Depreciation and Amortization (D&A)
1,798 1,633 1,577 1,551 1,624 1,787 1,265 1,208 1,061 916
Debt-free, Cash-free Net Working Capital to Revenue
8.51% 6.86% 7.17% 4.07% 3.98% 0.00% 5.08% 7.76% 3.38% 0.00%
Debt-free Net Working Capital to Revenue
19.08% 25.00% 25.31% 24.01% 33.87% 0.00% 38.66% 17.69% 13.35% 0.00%
Net Working Capital to Revenue
10.65% 19.66% 20.76% 22.13% 29.02% 0.00% 12.36% 16.23% 12.24% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$5.06 $4.36 $5.07 $0.00 $142.90 $2.41 $3.02 $2.27 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
683.30M 723.90M 752.14M 0.00 795.14M 799.64M 843.39M 838.96M 0.00 0.00
Adjusted Diluted Earnings per Share
$5.02 $4.33 $5.03 $0.00 $141.80 $2.39 $3.01 $2.25 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
689.50M 729.20M 752.14M 0.00 795.14M 799.64M 843.39M 838.96M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
676.48M 690.36M 752.14M 0.00 795.14M 799.64M 843.39M 838.96M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
3,733 3,445 2,931 2,600 1,406 0.00 1,873 2,298 1,473 887
Normalized NOPAT Margin
10.49% 9.86% 8.96% 8.90% 5.43% 0.00% 6.83% 8.84% 5.65% 3.81%
Pre Tax Income Margin
13.25% 11.49% 10.58% 10.62% 5.62% 0.00% 7.27% 7.78% 6.54% 4.30%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
8.47 11.13 10.87 10.85 4.28 0.00 0.00 6.38 4.99 3.05
NOPAT to Interest Expense
6.20 8.57 8.63 8.35 3.21 0.00 0.00 6.36 3.58 2.06
EBIT Less CapEx to Interest Expense
4.70 6.57 6.78 7.14 2.01 0.00 0.00 2.91 2.81 0.83
NOPAT Less CapEx to Interest Expense
2.43 4.01 4.54 4.64 0.94 0.00 0.00 2.89 1.40 -0.17
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
49.42% 31.74% 24.25% 35.22% 61.97% 38.15% 21.91% 24.86% 28.35% 52.54%
Augmented Payout Ratio
91.51% 131.58% 54.54% 68.58% 83.35% 93.04% 53.79% 25.01% 28.35% 52.54%

Quarterly Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Growth Metrics
- - - - - - - - -
Revenue Growth
3.41% 2.13% 3.82% -0.57% 1.65% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-18.94% 32.84% 13.78% 12.90% 51.81% 0.00% 0.00% 0.00% 0.00%
EBIT Growth
-101.06% 43.44% 13.25% 14.67% 9,350.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth
-62.25% 48.98% 4.29% 12.21% 2,283.84% 0.00% 0.00% 0.00% 0.00%
Net Income Growth
-185.96% 23.73% 5.39% 8.00% 467.74% 0.00% 0.00% 0.00% 0.00%
EPS Growth
-193.75% 5.21% 9.44% 16.05% 420.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
7.44% 12.67% -8.89% -9.12% -6.11% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth
-78.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
15.83% 27.21% 19.49% 9.40% 9.87% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
-23.83% -15.64% 8.92% 47.77% 0.00% -14.25% 4.32% 51.07% 0.00%
EBITDA Q/Q Growth
-70.79% -34.78% 9.53% 288.40% 0.00% -44.14% 8.68% 422.28% 0.00%
EBIT Q/Q Growth
-100.18% -44.92% 9.40% 879.89% 0.00% -56.51% 10.77% 80,650.00% 0.00%
NOPAT Q/Q Growth
-98.67% -33.22% 2.80% 4,020.55% 0.00% -53.25% 10.60% 87,442.41% 0.00%
Net Income Q/Q Growth
-113.82% -48.96% 6.11% 1,048.25% 0.00% -56.53% 8.75% 4,009.68% 0.00%
EPS Q/Q Growth
-114.85% -48.73% 4.79% 1,075.00% 0.00% -46.67% 11.11% 3,340.00% 0.00%
Operating Cash Flow Q/Q Growth
-124.14% 83.71% 0.07% 308.57% 0.00% 48.56% -0.18% 343.52% 0.00%
Free Cash Flow Firm Q/Q Growth
22.49% -50.07% -228.21% 53.37% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
5.02% -2.19% 9.80% 2.70% 0.00% -8.12% 0.53% 3.14% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
27.19% 35.63% 38.60% 38.07% 27.66% 33.98% 37.15% 37.39% 25.19%
EBITDA Margin
7.03% 18.33% 23.71% 23.58% 8.97% 14.09% 21.63% 20.76% 6.01%
Operating Margin
0.27% 12.45% 18.68% 18.95% 0.43% 9.02% 17.65% 16.61% 0.03%
EBIT Margin
-0.03% 12.58% 19.27% 19.18% 2.89% 8.96% 17.66% 16.63% 0.03%
Profit (Net Income) Margin
-1.45% 7.99% 13.21% 13.56% 1.75% 6.60% 13.01% 12.48% -0.48%
Tax Burden Percent
67.12% 71.83% 73.30% 75.53% 115.15% 75.89% 76.63% 76.81% 79.49%
Interest Burden Percent
7,300.00% 88.44% 93.53% 93.57% 52.38% 97.04% 96.14% 97.71% -1,950.00%
Effective Tax Rate
0.00% 14.49% 28.02% 24.81% -19.19% 19.07% 24.19% 24.02% 0.00%
Return on Invested Capital (ROIC)
0.21% 13.12% 15.67% 17.31% 0.64% 10.04% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.89% 9.57% 15.34% 16.32% 1.87% 8.43% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-0.41% 2.85% 4.99% 4.97% 0.57% 1.48% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-0.20% 15.97% 20.66% 22.28% 1.21% 11.51% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
-2.76% -10.81% 0.00% 0.00% 0.00% 15.36% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-0.02% 9.13% 13.79% 14.25% 2.22% 6.75% 0.00% 0.00% 0.00%
Return on Assets (ROA)
-1.06% 5.80% 9.46% 10.07% 1.34% 4.97% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-0.19% 15.25% 19.68% 21.47% 1.17% 11.09% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
15.67% 0.00% 15.47% 15.99% 16.07% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
13 944 1,414 1,375 33 634 1,356 1,226 1.40
NOPAT Margin
0.19% 10.64% 13.44% 14.24% 0.51% 7.30% 13.38% 12.62% 0.02%
Net Nonoperating Expense Percent (NNEP)
1.10% 3.55% 0.33% 0.98% -1.23% 1.60% 0.75% 0.28% 0.72%
Return On Investment Capital (ROIC_SIMPLE)
0.03% 2.59% - - - 1.92% - - -
Cost of Revenue to Revenue
72.81% 64.37% 61.40% 61.93% 72.34% 66.02% 62.85% 62.61% 74.81%
SG&A Expenses to Revenue
27.13% 21.79% 20.77% 20.18% 27.35% 21.17% 19.65% 20.96% 25.24%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.92% 23.18% 19.92% 19.12% 27.23% 24.96% 19.50% 20.77% 25.16%
Earnings before Interest and Taxes (EBIT)
-2.00 1,116 2,026 1,852 189 778 1,789 1,615 2.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
475 1,626 2,493 2,276 586 1,224 2,191 2,016 386
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
2.82 2.91 2.89 2.48 2.98 2.46 1.83 1.83 1.70
Price to Tangible Book Value (P/TBV)
7.06 6.73 6.42 5.48 6.77 4.81 3.57 3.49 3.33
Price to Revenue (P/Rev)
1.66 1.77 1.79 1.47 1.70 1.46 0.00 0.00 0.00
Price to Earnings (P/E)
18.13 18.00 18.14 15.05 17.93 16.11 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 2.56% 2.71% 1.95% 1.95% 0.00% 0.00% 0.00%
Earnings Yield
5.52% 5.56% 5.51% 6.64% 5.58% 6.21% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.13 2.28 2.25 2.02 2.36 2.23 1.65 1.66 1.56
Enterprise Value to Revenue (EV/Rev)
2.02 2.07 2.11 1.74 1.97 1.62 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
10.53 10.54 11.32 9.70 11.47 9.74 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
14.49 14.19 15.38 13.22 15.79 13.54 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
19.21 19.40 21.35 17.76 21.06 17.58 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.35 14.75 15.91 12.62 13.87 11.29 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.70 0.61 0.60 0.61 0.61 0.54 0.50 0.43 0.44
Long-Term Debt to Equity
0.64 0.48 0.46 0.46 0.47 0.45 0.42 0.33 0.34
Financial Leverage
0.47 0.30 0.33 0.30 0.31 0.18 0.22 0.21 0.20
Leverage Ratio
2.28 2.21 2.16 2.13 2.13 2.08 2.10 2.03 2.04
Compound Leverage Factor
166.42 1.95 2.02 2.00 1.12 2.02 2.02 1.99 -39.72
Debt to Total Capital
41.21% 37.94% 37.48% 37.95% 37.92% 35.00% 33.47% 30.03% 30.75%
Short-Term Debt to Total Capital
3.83% 8.15% 8.68% 9.31% 8.95% 5.61% 5.46% 6.73% 7.04%
Long-Term Debt to Total Capital
37.38% 29.79% 28.80% 28.64% 28.97% 29.39% 28.01% 23.30% 23.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.26% 3.38% 3.48% 2.10% 2.18% 2.31% 2.59% 2.74% 2.78%
Common Equity to Total Capital
55.53% 58.68% 59.03% 59.95% 59.90% 62.69% 63.94% 67.23% 66.46%
Debt to EBITDA
2.28 2.00 2.11 2.09 2.11 2.00 0.00 0.00 0.00
Net Debt to EBITDA
1.69 1.36 1.50 1.39 1.46 0.80 0.00 0.00 0.00
Long-Term Debt to EBITDA
2.07 1.57 1.62 1.58 1.61 1.68 0.00 0.00 0.00
Debt to NOPAT
4.16 3.68 3.98 3.82 3.86 3.61 0.00 0.00 0.00
Net Debt to NOPAT
3.08 2.50 2.83 2.54 2.67 1.45 0.00 0.00 0.00
Long-Term Debt to NOPAT
3.78 2.89 3.06 2.89 2.95 3.03 0.00 0.00 0.00
Altman Z-Score
2.66 2.89 2.92 2.80 2.94 2.83 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
4.56% 4.52% 4.75% 3.66% 3.77% 3.70% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
1.63 1.37 1.39 1.43 1.37 1.69 1.78 1.56 1.54
Quick Ratio
0.97 0.83 0.88 0.85 0.81 1.08 1.27 1.07 1.01
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
-4,626 -5,969 -3,977 -1,212 -2,599 0.00 0.00 0.00 0.00
Operating Cash Flow to CapEx
-108.03% 147.49% 352.97% 556.18% 0.00% 402.49% 426.96% 405.46% -205.83%
Free Cash Flow to Firm to Interest Expense
-25.56 -37.31 -24.25 -7.82 -19.54 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-3.64 17.06 9.06 9.58 -5.35 26.63 12.45 22.38 -8.28
Operating Cash Flow Less CapEx to Interest Expense
-7.01 5.49 6.49 7.86 -3.60 20.01 9.53 16.86 -12.31
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.73 0.73 0.72 0.74 0.77 0.75 0.00 0.00 0.00
Accounts Receivable Turnover
7.20 7.63 5.71 5.83 7.38 7.94 0.00 0.00 0.00
Inventory Turnover
4.82 5.06 5.18 5.19 5.05 5.42 0.00 0.00 0.00
Fixed Asset Turnover
1.74 1.81 1.80 1.87 1.90 1.96 0.00 0.00 0.00
Accounts Payable Turnover
8.38 7.20 7.74 6.59 8.55 7.56 0.00 0.00 0.00
Days Sales Outstanding (DSO)
50.67 47.85 63.92 62.63 49.48 45.99 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
75.80 72.18 70.43 70.35 72.33 67.37 0.00 0.00 0.00
Days Payable Outstanding (DPO)
43.58 50.72 47.17 55.35 42.68 48.26 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
82.89 69.32 87.18 77.63 79.12 65.09 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
33,944 32,322 33,047 30,097 29,305 25,409 27,656 27,510 26,673
Invested Capital Turnover
1.13 1.23 1.17 1.22 1.25 1.38 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
4,639 6,913 5,391 2,587 2,632 0.00 0.00 0.00 0.00
Enterprise Value (EV)
72,336 73,568 74,494 60,912 69,033 56,643 45,711 45,573 41,537
Market Capitalization
59,510 62,852 63,321 51,487 59,550 51,194 39,821 39,883 36,118
Book Value per Share
$31.22 $31.80 $32.04 $30.18 $29.10 $27.72 $28.94 $29.01 $28.26
Tangible Book Value per Share
$12.47 $13.74 $14.45 $13.67 $12.79 $14.16 $14.82 $15.18 $14.43
Total Capital
38,028 36,818 37,056 34,569 33,414 33,263 34,043 32,457 31,978
Total Debt
15,671 13,968 13,890 13,118 12,672 11,642 11,395 9,748 9,834
Total Long-Term Debt
14,213 10,969 10,672 9,900 9,680 9,776 9,535 7,563 7,583
Net Debt
11,587 9,472 9,881 8,699 8,755 4,681 5,008 4,801 4,529
Capital Expenditures (CapEx)
610 1,851 421 267 -233 602 382 403 326
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,636 3,027 4,310 3,848 3,396 2,397 3,262 3,313 2,576
Debt-free Net Working Capital (DFNWC)
6,988 6,786 7,390 7,783 6,704 8,738 8,984 7,588 7,226
Net Working Capital (NWC)
5,530 3,787 4,172 4,565 3,712 6,872 7,124 5,403 4,975
Net Nonoperating Expense (NNE)
111 235 25 66 -81 61 38 14 32
Net Nonoperating Obligations (NNO)
11,587 9,472 9,881 8,646 8,563 3,788 5,008 4,801 4,529
Total Depreciation and Amortization (D&A)
477 510 467 424 397 446 402 401 384
Debt-free, Cash-free Net Working Capital to Revenue
10.16% 8.51% 12.18% 10.99% 9.69% 6.86% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
19.52% 19.08% 20.88% 22.24% 19.12% 25.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
15.45% 10.65% 11.79% 13.04% 10.59% 19.66% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) $1.02 $1.99 $1.89 $0.16 $0.97 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
676.70M 683.30M 681.60M 685.50M 687.80M 723.90M 0.00 0.00 0.00
Adjusted Diluted Earnings per Share
($0.15) $1.01 $1.97 $1.88 $0.16 $0.96 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
676.70M 689.50M 685.50M 688.80M 693.40M 729.20M 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
676.00M 676.48M 679.34M 682.78M 686.68M 690.36M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
2.80 912 1,350 1,298 14 611 1,344 1,212 -2.10
Normalized NOPAT Margin
0.04% 10.28% 12.84% 13.45% 0.21% 7.04% 13.27% 12.48% -0.03%
Pre Tax Income Margin
-2.16% 11.13% 18.02% 17.95% 1.52% 8.69% 16.98% 16.25% -0.61%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
-0.01 6.98 12.35 11.95 1.42 8.55 13.66 22.12 0.02
NOPAT to Interest Expense
0.07 5.90 8.62 8.87 0.25 6.96 10.35 16.79 0.02
EBIT Less CapEx to Interest Expense
-3.38 -4.59 9.79 10.23 3.17 1.93 10.74 16.60 -4.00
NOPAT Less CapEx to Interest Expense
-3.30 -5.67 6.05 7.15 2.00 0.35 7.43 11.27 -4.01
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
29.92% 49.42% 49.72% 43.63% 53.81% 31.74% 0.00% 0.00% 0.00%
Augmented Payout Ratio
67.18% 91.51% 116.48% 134.61% 158.87% 131.58% 0.00% 0.00% 0.00%

Frequently Asked Questions About CRH's Financials

When does CRH's fiscal year end?

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023. View CRH's forecast to see where analysts expect CRH to go next.

What is CRH's operating income?
CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:
  • Total Gross Profit: $12.70 billion
  • Total Operating Expenses: $7.78 billion
How has CRH revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.



This page (NYSE:CRH) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners